Source file signed link, expires in 15 minutes
Extracted text 32
Page 1
PAPARAN PUBLIK PUBLIC EXPOSE PT Darya-Varia Laboratoria Tbk Jakarta, 18 June 2025
Page 2
TOPIK
TOPICS
Tinjauan Pasar
Market Overview
Sekilas Darya-Varia
Darya-Varia at a glance
Tinjauan Bisnis
Business Overview
Page 3
TINJAUAN PASAR MARKET OVERVIEW
Page 4
TINJAUAN PASAR
MARKET OVERVIEW
Ekonomi Indonesia tahun 2024 tumbuh sebesar 5,03%
Indonesia’s economy grew by 5.03% in 2024
Konsumsi Rumah Tangga
Household Consumption
Faktor Investasi Infrastruktur &
Pendorong Digital
Driving Investment in Infrastructure &
Factors Digital
Stabilitas Politik
Political Stability
Source : Rilis Berita Resmi Statistik Badan Pusat Statistik (5 February 2025)
Page 5
TINJAUAN PASAR
MARKET OVERVIEW
Kebijakan Moneter BI di 2024 membantu menjaga stabilitas ekonomi
BI’s monetary policy in 2024 helped maintain economic stability
BI 7-Day Reverse Repo Rate (BI7DRR): Inflation Rate:
25 Basis
points
6.00%
1.57%
Nilai tukar Rupiah terhadap Dolar AS sangat fluktuatif sepanjang 2024
The exchange rate of the Indonesian Rupiah against the US Dollar exhibited high volatility throughout 2024
2024 vs 2023:
IDR/USD:
Rp15,850/USD 3.9%
Page 6
TINJAUAN PASAR
MARKET OVERVIEW
Cakupan Jaminan Kesehatan Nasional (JKN) terus Ketergantungan pada bahan baku impor masih
meningkat hingga akhir 2024 menjadi tantangan
The coverage of Indonesia’s National Health Insurance (JKN) Reliance on imported raw materials continues to pose a
has continued to expand up to the end of 2024 challenge
Population
% Coverage Size >90%
Bahan Baku Impor
Imported Raw Materials
> 98% 277 Million People
Page 7
TINJAUAN PASAR
MARKET OVERVIEW
Pertumbuhan Industri Farmasi Indonesia tahun 2024 mencerminkan pemulihan pasca
pandemi yang kuat dari kinerja sebelumnya
The growth of Indonesia’s Pharmaceutical Industry in 2024 reflects a solid post-pandemic recovery from its previous
performance
13% 15%
8%
Industri Farmasi Obat Bebas Obat Resep
Pharmaceutical Industry OTC Prescription
24%
Non Generik
Generik (selain vaksin
7% /excl. vaccines)
Page 8
SEKILAS DARYA-VARIA DARYA-VARIA AT A GLANCE
Page 9
SEKILAS DARYA-VARIA
DARYA-VARIA AT A GLANCE
Visi
Vision
Menjadi perusahaan terbaik yang menyediakan solusi
kesehatan berkualitas di Indonesia
We shall be the best provider of quality health and wellness solutions in
Indonesia
Misi
Mision
Kami membangun Indonesia yang lebih sehat setiap orang di
setiap waktu melalui produk dan pelayanan unggulan, bekerja
sama sebagai satu keluarga “BERSATU”
We build a healthier Indonesia one person at a time with market leading
products and services, working together as one “BERSATU” family
Page 10
SEKILAS DARYA-VARIA
DARYA-VARIA AT A GLANCE
Bisnis Obat Resep Bisnis Consumer Health Bisnis Konsultasi Manajemen
Prescription Business Consumer Health Business Management Consultancy Business
Bisnis Ekspor & Toll Manufacturing
Toll Manufacturing & Export Business
Indonesia Philippines Vietnam Myanmar Mongolia Malaysia Singapore
Page 11
SEKILAS DARYA-VARIA
DARYA-VARIA AT A GLANCE
TONGGAK SEJARAH
MILESTONE
The Company acquired 60% of share
ownership in PT Pradja Pharin, with the DVLIL Which owned 89.5% of the FED and DVILL Transferred their Signed MOU with PT Astra
The Company was established under IPO of 10,000,000 shares and remaining 40% of outstanding shares Company’s Shares, is fully owned by 92.66% share ownership to Blue Komponen Indonesia (ASKI) to
the name of PT Darya-Varia became a public company acquired in 1996 for full ownership Far East Drug Co Ltd (FED) Sphere Singapore Pte Ltd. develop local medical devices and
Laboratoria strengthen our position in
Indonesia's healthcare industry
1976 1994 1995 2001 2006 2024
2014 2017 2021 2022 2023 2024
PT Pradja Pharin was merged Awarded the Best 50 Companies Selected as one of Asia Best Won Top Corporate Awards Awards Best Place to work Established a subsidiary, PT Varia
into the Company, an action by of 2017 by Forbes Indonesia Performing Companies at the for the third consecutive 2023 in Indonesia & Top Interhealth Indonesia, to strengthen
which the Company became the 2021 Asia Corporate Excellence & years from 2020 to 2022 Corporate Award 2023 market position and support
sole surviving entity Sustainability Awards accelerated business expansion
Page 12
SEKILAS DARYA-VARIA
DARYA-VARIA AT A GLANCE FASILITAS PRODUKSI
PRODUCTION FACILITY
Gunung Putri Plant Citeureup Plant
Page 13
TINJAUAN BISNIS BUSINESS OVERVIEW
Page 14
TINJAUAN BISNIS
BUSINESS OVERVIEW
Strategi Bisnis Darya-Varia 2024 mencakup 5 bidang utama
2024 DVL’s Business Strategy covered 5 areas
Memperkuat kembali Mempertahankan momentum
segmen Consumer Health dari segmen obat resep
Boost our Consumer Health segment Keeping the momentum of our Mengejar efisiensi
prescription segment proses operasional dan
struktur biaya
Continued to target
inefficiencies in our
Memperkaya portofolio dengan Menjajaki peluang kemitraan operational processes and
meluncurkan sejumlah produk dan aliansi strategis cost structure
baru
Exploring strategic partnership and
Strengthen our portfolio by launching alliance opportunities
a range of new products
Page 15
TINJAUAN BISNIS
BUSINESS OVERVIEW
Total Pendapatan DVL Tahun 2024 mencapai Rp2,09 Triliun, +10% vs 2023 – melampaui
target pertumbuhan 7% yang kami nyatakan dalam Laporan Tahunan 2023
DVL’s Total Revenue in 2024 reached Rp2.09 Trillion, +10% vs 2023. This growth achievement was higher than the 7% growth we had
targeted for the year, as stated in the Company’s 2023 Annual Report.
2.088 Pertumbuhan Pertumbuhan
1.891 Laba Bersih
Pendapatan
Revenue Growth: Net Profit Growth:
156
10% 146 7%
2023 2024 2023 2024
Total Pendapatan 2023 vs 2024 Laba Bersih 2023 vs 2024
Total Revenues 2023 vs 2024 Net Profit 2023 vs 2024
*) dalam Milliar Rupiah | in Billion Rupiah
*) dalam Milliar Rupiah | in Billion Rupiah
Page 16
TINJAUAN BISNIS
BUSINESS OVERVIEW
PROGRAM CSR 2024
2024 CSR PROGRAM
DESA SEHAT - Pabrik Gunung Putri & Citeureup HALALPRENEUR PROGRAM 2024
HEALTHY VILLAGE - Gunung Putri & Citeureup Plant 2024 HALALPRENEUR PROGRAM
Program Desa/Kelurahan Sehat adalah inisiatif unggulan Darya-Varia sejak Inisiatif antara Darya-Varia, Kementrian Perindustrian dan
2019 yang bertujuan menciptakan lingkungan bersih dan sehat, Politeknik APP Jakarta untuk mempercepat sertifikasi halal
meningkatkan kualitas hidup dan produktivitas warga, serta mendorong bagi UMKM
kemandirian, ketahanan pangan, dan pertumbuhan ekonomi lokal.
Collaborative initiative between Darya-Varia, Ministry of Industry and
The Healthy Village Program is a flagship CSR initiative by Darya-Varia since 2019, Politeknik APP Jakarta, accelerating halal certification for Micro Small
aimed at creating a clean and healthy environment, improving residents' quality of and Medium Enterprises
life and productivity, while promoting self-reliance, food security, and local economic
growth.
Page 17
TINJAUAN BISNIS
BUSINESS OVERVIEW
PROGRAM CSR 2024
2024 CSR PROGRAM
Donasi obat untuk korban banjir
PROGRAM PENCEGAHAN STUNTING - bersama Yayasan Dokter Peduli &
Kolaborasi dengan Kemenkes APAD (Asia Pacific Alliance for
Disaster Management) Indonesia
STUNTING PREVENTION PROGRAM -
In collaboration with Ministry of Health Medicine donation for flood victims with
doctorSHARE Foundation & APAD (Asia Pacific
Alliance for Disaster Management) Indonesia
Page 18
TINJAUAN BISNIS BUSINESS OVERVIEW (Darya-Varia Scholarship for Talented Aspiring Women Researchers) Program beasiswa yang khusus ditujukan untuk mendukung dan memberdayakan peneliti perempuan di bidang STEM agar terus berkembang & berkontribusi dalam lingkungan yang inklusif A scholarship program specifically aimed at supporting and empowering female researchers in the STEM field, enabling them to continue developing their potential and contributing within an inclusive environment
Page 19
TINJAUAN BISNIS
BUSINESS OVERVIEW
Dalam proses menuju Target Keberlanjutan 2030, Perseroan mengambil
langkah inovatif untuk mengurangi limbah operasional pabrik
In the process of moving toward the 2030 Sustainability Target, the Company has taken innovative steps
to reduce operational factory waste
Konversi Produk yang bermanfaat - Semen
Limbah Pabrik Useful Product - Cement
Plant Waste Conversion
Bersama Pelaku
Industri Semen
Teamed up with
Cement Manufactures
Page 20
TINJAUAN BISNIS
BUSINESS OVERVIEW
Didirikan pada Agustus 2024, PT Varia
Interhealth Indonesia dibentuk untuk
mempercepat kemampuan Perseroan dalam
mengembangkan dan memperkuat
posisinya di sektor kesehatan
Established in August 2024, PT Varia Interhealth
Indonesia was formed to accelerate the Company's
ability to develop and strengthen its position in the
health sector
Page 21
TINJAUAN BISNIS
BUSINESS OVERVIEW
BUSINESS CONSUMER HEALTH
CONSUMER HEALTH BUSINESS
Bisnis Consumer Health mencatat pertumbuhan 20% vs 2023 -
Pendapatan (Rp Miliar)
Revenue (Rp Billion)
Jauh diatas pertumbuhan pasar yang sebesar 8%
1.154 Consumer Health Business recorded an aggregate growth of 20% vs 2023 -
Outperforming the market growth of 8%
Page 22
TINJAUAN BISNIS
BUSINESS OVERVIEW
VITAMIN E SKIN SUPPLEMENT IMMUNITY + ENERGY
76% 82% 57% 64% 12% 20%
Value Share Unit Share Value Share Unit Share Value Share Unit Share
Natur-E mempertahankan posisinya Natur-E juga unggul di segmen total Enervon memperoleh pangsa pasar
sebagai pemimpin pasar di kategori skin supplement dan terus memimpin dalam pangsa
vitamin E Natur-E also led in the total skin supplement unit di pasar produk bermerek untuk
Natur-E further strengthened its dominance segment and gained shares
imunitas & stamina
in the vitamin E supplement category
Enervon gained market shares and continues
to lead in unit shares in branded
immunity+stamina market
Source: AC Nielsen FY 2024 Retail Audit, for Branded Vitamins
Page 23
TINJAUAN BISNIS
BUSINESS OVERVIEW
Produk Baru |New Product
Meluncurkan produk baru Herbablend Daily Health, suplemen herbal all-in-one yang mengandung buah-buahan, sayuran, dan
habbatussauda untuk mendukung kebutuhan nutrisi harian, serta Natur-E face and body lotion yang diperbarui dengan formula
yang lebih unggul dan kemasan yang lebih modern
Launched New Products Herbablend Daily Health, an all-in-one herbal supplement containing fruits, vegetables, and habbatussauda to support daily nutrition, and
revitalized Natur-E face and body lotion with more advanced formula and modernized packaging
Page 24
TINJAUAN BISNIS
BUSINESS OVERVIEW
BISNIS OBAT RESEP
PRESCRIPTION BUSINESS
Penghentian salah satu SKU utama akibat kendala pasokan dan
Pendapatan (Rp Miliar) ketatnya persaingan pasar merupakan tantangan bagi Perseroan di
Revenue (Rp Billion) tahun 2024
705 The discontinuance of one major SKU due to supply constraints and heightened market
competition were the challenges for the Company in 2024
Peluncuran 5 SKU baru dalam berbagai kategori
Launched 5 new SKUs across various categories within the prescription business segment
Page 25
TINJAUAN BISNIS
BUSINESS OVERVIEW
BISNIS TOLL
MANUFACTURING & EKSPOR
Pendapatan (Rp Miliar)
TOLL MANUFACTURING & EXPORT Revenue (Rp Billion)
BUSINESS 202
Markets
Indonesia Philippines Vietnam Myanmar Mongolia Malaysia Singapore
Page 26
TINJAUAN BISNIS
BUSINESS OVERVIEW
Keselamatan karyawan menjadi prioritas utama Perseroan
Employee’s safety has always been the Company’s top priority
Penghargaan Kecelakaan Nihil| Zero Accident Awards
Citeureup Plant Gunung Putri Plant
Komposisi Karyawan Wanita tahun 2024
2024 Female Employee Composition
1 Director 44 Manager
2 Operating Director 134 Supervisor
24 Senior Manager 360 Staff
Page 27
TINJAUAN BISNIS
BUSINESS OVERVIEW
PROGRES KEBERLANJUTAN 2024
2030 Sustainability Targets:
SUSTAINABILITY PROGRESS IN 2024
Menurunkan emisi gas rumah
kaca hingga 30%
Reduce greenhouse gas
emissions by up to 30%
Produksi Limbah hingga
30% Pabrik Gunung Putri meningkatkan efisiensi energi melalui pemasangan
Waste Production up to 30% economizer boiler, lampu bertenaga surya, dan sistem HVAC yang
dioptimalkan sehingga dapat mengurangi gas rumah kaca sebesar 12%
Gunung Putri Plant, energy efficiency was improved through the installation of a
economizer boiler, solar-powered lighting fixtures, and optimized HVAC system and also
Konsumsi Air hingga 30% reduced greenhouse gas emissions intensity by 12% Company-wide
Water Consumption up to 30%
Pabrik Gunung Putri memanfaatkan limbah lumpur sebagai bahan baku
untuk semen alih-alih membuangnya, sementara Pabrik
Citeureup mengoptimalkan pengelolaan limbah botol kaca
Nihil Limbah Waste management initiatives at the Gunung Putri Plant eliminated landfill waste by
Zero Landfill
reusing sludge as raw material for cement, while Citeureup Plant optimized glass bottle
waste disposal
Page 28
TINJAUAN BISNIS
BUSINESS OVERVIEW
PENGHARGAAN 2024
2024 AWARDS
Page 29
TINJAUAN BISNIS BUSINESS OVERVIEW LAPORAN TAHUNAN 2024 2024 ANNUAL REPORT Laporan Tahunan 2024 Tersedia di website kami: www.darya-varia.com 2024 Annual Report Available in our website: www.darya-varia.com
Page 30
TINJAUAN BISNIS KUARTAL 1 2025
2025 Q1 BUSINESS OVERVIEW
Page 31
TINJAUAN BISNIS KUARTAL 1
FIRST QUARTER BUSINESS OVERVIEW
KINERJA Q1 2025
Q1 2025 PERFORMANCE
Perseroan menunjukan pertumbuhan pendapatan dan laba periode Q1 2025 vs Q1 2024
Year-on-year growth by the Company increased revenue & profit for the period Q1 2025 vs Q1 2024
544
2,3%
Pertumbuhan Pendapatan
532 Revenue Growth 17%
Pertumbuhan Laba
Consumer Health : Profit Growth
9,3% 79
67
Toll Manufacturing &
Prescription: Q1 2024 Q1 2025
Q1 2024 Q1 2025 Export :
(1%) (15%) Total Laba (dalam miliar Rupiah)
Total Pendapatan (dalam miliar Rupiah) Total Profit (in billion Rupiah)
Total Revenues (in billion Rupiah)
Page 32
PT DARYA-VARIA LABORATORIA Tbk HEAD OFFICE: SOUTH QUARTER TOWER C 18TH - 19TH FLOOR JL. R.A. KARTINI KAV. 8 JAKARTA 12430 INDONESIA
Names mentioned 12 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Pusat Statistik
p.4
unresolved
org
PT Pradja Pharin
p.11 ×2
unresolved
org
PT Astra
p.11
unresolved
org
PT Darya-Varia
p.11
unresolved
org
Far East Drug Co Ltd
p.11
unresolved
org
Sphere Singapore Pte Ltd.
p.11
unresolved
org
PT Varia
p.11
unresolved
org
Ministry of Industry
p.16
unresolved
org
Yayasan Dokter Peduli
p.17
unresolved
org
Ministry of Health
p.17
unresolved
org
PT Varia Interhealth Indonesia
p.20 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.